VERTANICAL’s VER-01 gains FDA breakthrough status for low back pain
Pharmaceutical Technology
VERTANICAL has received breakthrough therapy designation from the US FDA for VER-01, its investigational non-opioid treatment for chronic low back pain.
pharminent
May 19, 2026 (Last updated: May 21, 2026)
Pharmaceutical Technology
VERTANICAL has received breakthrough therapy designation from the US FDA for VER-01, its investigational non-opioid treatment for chronic low back pain.
